HUMAN ASTROVIRUS - ANVISA Registration 80826840123
Access comprehensive regulatory information for HUMAN ASTROVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80826840123 and manufactured by R-BIOPHARM AG. The registration is held by SERION BRASIL IMPORTAÇÃO E DISTRIBUIÇÃO DE PRODUTOS DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA, and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80826840123
25351581189201998
14021899000133
Company Information
Dates and Status
Oct 21, 2019
VIGENTE
09/18/2025 19:00:01
HUMAN ASTROVIRUS
FASTLINE ASTROVÍRUS Ag
KHAYROS DIAGNOSTICA FABRICACAO, COMERCIALIZACAO E DISTRIBUICAO DE PRODUTOS LTDA
80105220122
Mar 13, 2023
ROTAVIRUS
RIDASCREEN ROTAVIRUS
R-BIOPHARM AG
80826840134
Dec 02, 2019
ADENOVIRUS
RIDASCREEN ADENOVIRUS
R-BIOPHARM AG
80826840124
Oct 21, 2019
ROTAVIRUS
RIDASCREEN® Rotavirus
R-BIOPHARM AG
82890930003
Jan 27, 2025
ADENOVIRUS
RIDASCREEN® Adenovirus
R-BIOPHARM AG
82890930001
Jan 27, 2025